Sutro Biopharma Inc (STRO)
4.275
+0.03
(+0.71%)
USD |
NASDAQ |
May 08, 14:54
Sutro Biopharma Total Liabilities (Quarterly): 321.09M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 321.09M |
| September 30, 2023 | 319.39M |
| June 30, 2023 | 310.18M |
| March 31, 2023 | 172.60M |
| December 31, 2022 | 189.90M |
| September 30, 2022 | 170.97M |
| June 30, 2022 | 176.56M |
| March 31, 2022 | 83.30M |
| December 31, 2021 | 88.84M |
| September 30, 2021 | 87.89M |
| June 30, 2021 | 52.29M |
| March 31, 2021 | 51.19M |
| Date | Value |
|---|---|
| December 31, 2020 | 62.06M |
| September 30, 2020 | 63.12M |
| June 30, 2020 | 70.78M |
| March 31, 2020 | 71.79M |
| December 31, 2019 | 58.58M |
| September 30, 2019 | 61.77M |
| June 30, 2019 | 69.26M |
| March 31, 2019 | 71.74M |
| December 31, 2018 | 91.60M |
| September 30, 2018 | 286.46M |
| June 30, 2018 | 177.20M |
| December 31, 2017 | 149.77M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
51.19M
Minimum
Mar 2021
321.09M
Maximum
Dec 2023
130.61M
Average
83.30M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| AnaptysBio Inc | 364.29M |
| ABVC BioPharma Inc | 6.362M |
| Reviva Pharmaceuticals Holdings Inc | 17.98M |
| Flora Growth Corp | 17.22M |
| Journey Medical Corp | 56.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 470.74M |
| Shareholders Equity (Quarterly) | 149.65M |
| Debt to Equity Ratio | 0.0271 |
| Current Ratio | 4.497 |
| Net Debt Paydown Yield | 1.16% |